# Acitretin or Tazarotene Gel and Excimer Laser for Treatment of Psoriasis

> **NCT01094717** · NA · TERMINATED · sponsor: **University of Utah** · enrollment: 13 (actual)

## Conditions studied

- Psoriasis

## Interventions

- **DRUG:** Acitretin 25Mg Oral Capsule
- **DEVICE:** Excimer laser
- **DRUG:** Tazarotene 0.1% Gel,Top
- **DEVICE:** Sham excimer laser

## Key facts

- **NCT ID:** NCT01094717
- **Lead sponsor:** University of Utah
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2010-01
- **Primary completion:** 2011-09
- **Final completion:** 2011-10
- **Target enrollment:** 13 (ACTUAL)
- **Why stopped:** lack of efficacy and lack of funding
- **Last updated:** 2019-06-26


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01094717

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01094717, "Acitretin or Tazarotene Gel and Excimer Laser for Treatment of Psoriasis". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT01094717. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*